Dr. Roy L. Freeman, MD

Dr. Freeman practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Freeman's NPI, 1518905876, was assigned on June 2, 2006. Dr. Freeman holds Massachusetts license 45392.

Dr. Freeman's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Freeman's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Freeman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freeman practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Freeman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Freeman is licensed in Massachusetts.

CMS data shows 425 Medicare services from Dr. Freeman across 7 procedure codes in 2024, for 119 Medicare patients. Medicare paid $21,585 for them.

CMS counts 119 Medicare patients who saw Dr. Freeman in 2024. The largest group is 65 to 74, with 50 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Freeman's median patient age at 44, with 73% women.

In 2024, Dr. Freeman wrote 54 Medicare Part D claims for 16 patients. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $4,801 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Freeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freeman as offering telehealth.

Dmand AI links 72 papers to Dr. Freeman, published from 2018 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Neuralgia, Autonomic Nervous System Diseases and Hypotension, Orthostatic. Dr. Freeman has published most often in Pain. Dr. Freeman's most frequent co-authors are Christopher H. Gibbons, MD, Horacio Kaufmann, MD and Gail Kurr Adler, MD, PhD.

Dmand AI links Dr. Freeman to 2 clinical trials. Conditions studied include Hypoglycemia and Glucose Metabolism Disorders. Brigham and Women's Hospital sponsors the most, 2.

CMS Open Payments shows 169 general payments to Dr. Freeman from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. GW Pharmaceuticals plc paid the most, $133,506. It also lists 14 research payments totaling $56,747 from 2017 to 2024.